There was a resurgence within the debate in regards to the scientific use of Psychedelic therapies or psychedelic-assisted psychotherapy (PAP).  There’s been elevated legalization of drugs and ketamine has been the most-studied psychedelic drug for its promising response to treating psychological well being circumstances particularly in relation to therapeutic sufferers from previous trauma in addition to nervousness and despair. Journey Medical is a market that connects licensed psychological well being professionals with sufferers in search of care to offer psychedelic-assisted psychotherapy beginning with ketamine-assisted psychotherapy. The corporate focuses on a collaborative care mannequin to unlock a brand new care pathway for sufferers for whom conventional pharmacological routes haven’t labored. For psychotherapists on the platform, Journey Medical has constructed the framework to manage these frontier therapies of their practices by way of schooling, coaching, and peer assist sources.  For sufferers, the platform handles eligibility, prescriptions, and the event of therapy plans.  Since launching a yr in the past, Journey has attracted 700+ suppliers which have handled 1000+ sufferers.

AlleyWatch caught up with Journey Medical Cofounder and CEO Jonathan Sabbagh to be taught extra in regards to the enterprise, the corporate’s strategic plans, newest spherical of funding, and far, rather more…

Who had been your buyers and the way a lot did you elevate?
Our Sequence A marked a further $8.5M in funding led by Union Sq. Ventures with participation from AlleyCorp, Fifty Years, In a position Companions, Gaingels, Palo Santo, PsyMed Ventures, Coalition Companions, Mystic Ventures, Colibri, Satori Capital, and different notable angel buyers. This spherical brings Journey Medical’s complete funding to ~$12M.

Inform us in regards to the services or products that Journey Medical gives.
Journey Medical is on a mission to remodel the rising psychological well being disaster by accelerating the adoption of frontier therapies that result in lasting enhancements in scientific outcomes. We’ve got constructed a turnkey healthtech platform to securely and successfully broaden entry to a robust modality often known as Psychedelic-Assisted Psychotherapy, the supervised use of psychedelics as an adjunct to psychotherapy.  We’ve got began with Ketamine-Assisted Psychotherapy (KAP) and can broaden to different psychotherapeutic therapies sooner or later as they proceed to be validated, researched, and permitted for broad use by the FDA.   As a two-sided market, Journey Medical’s platform serves each licensed psychological well being professionals and eligible sufferers.  For psychotherapists, our platform offers them every part they should grow to be empowered KAP suppliers in their very own observe: on-demand entry to a world-class medical workforce, in-depth KAP schooling and coaching alternatives, entry to a neighborhood of friends, and a strong library {of professional} sources. For sufferers, Journey Medical’s KAP-trained medical workforce takes on all medical actions, together with eligibility, prescriptions and therapy plan. This collaborative-care method allows larger requirements of care and enhanced scientific outcomes.

What impressed the beginning of Journey Medical?
We’re in the midst of a staggering psychological well being disaster, one which has been exacerbated for the reason that begin of the COVID-19 pandemic. Right now, 1 in 5 adults within the US lives with a type of psychological sickness, and treatment-resistant circumstances are on the rise: roughly 30% of individuals recognized with main depressive dysfunction are resistant to standard therapies. Regardless of the 41+ million folks engaged in psychotherapy, present therapies usually don’t present lasting reduction or long-term enhancements in high quality of life. With restricted innovation in psychiatry during the last 50 years and a rising US psychiatrist scarcity, new interventions with profound, sustainable influence are urgently wanted.
At Journey Medical, we’re on a mission to remodel the psychological well being disaster by accelerating the adoption of frontier therapies to offer sufferers with lasting improved outcomes. We’ve got constructed a turnkey healthtech platform to securely and successfully broaden entry to a robust modality, often known as Psychedelic-Assisted Psychotherapy (PAP), which focuses on the supervised use of psychedelic medicines as an adjunct to psychotherapy.
Earlier than we based Journey Medical, there was restricted alternative for sufferers to reliably and affordably entry these transformative therapies. Equally, it was a cumbersome and difficult course of for psychotherapists to supply these therapies as an adjunct to remedy. Journey Medical has constructed a novel platform anchored in a patient-centered collaborative care mannequin that honors the connection between psychotherapists and sufferers, whereas making PAP considerably extra accessible.

How is Journey Medical totally different?
Earlier than Journey Medical, accessing Ketamine-Assisted Psychotherapy was very troublesome for sufferers.  Ketamine therapy is pricey and inaccessible to most sufferers (IV clinics can value 1000’s of {dollars} per therapy).  Furthermore, ketamine therapy often takes place exterior the context of psychotherapy. Journey Medical gives sufferers with a turnkey therapy possibility that enables them to entry each the medical care and the psychotherapy safely and successfully.

• As an alternative of hiring psychological well being practitioners, we empower tens of millions of impartial practitioners within the US to supply psychedelic remedy therapies in their very own observe. By bringing psychedelic-assisted remedy to present therapist-patient relationships, we make KAP extra accessible and efficient for individuals who want it. This can be a recreation changer for practitioners who lack the infrastructure to supply a lot of these therapies.  As well as, this mannequin permits psychotherapists to maintain all of their income and develop their enterprise.
• Our patient-centered collaborative care mannequin permits us to offer a top quality of care at scale in an unprecedented means: licensed psychotherapists within the community tackle the psychotherapy, whereas Journey Medical’s in-house medical workforce takes on affected person eligibility, therapy plan and consequence monitoring.

There’s a psychiatrist scarcity within the US, along with a scarcity of psychedelics-informed prescribers.  At Journey Medical, we now have a world-class, in-house medical workforce skilled in Ketamine-Assisted Psychotherapy led by Dr. Kyle Lapidus, MD PhD, world knowledgeable in ketamine therapy.

What market does Journey Medical goal and the way massive is it?
At the moment, 1.3M impartial psychotherapists (together with licensed psychological well being professionals resembling Psychologists, Licensed Psychotherapists, Social Employees) lack entry to ketamine prescribing docs to supply KAP to their sufferers. In the meantime, 50M+ sufferers lack entry to vetted impartial KAP suppliers (main them to go to ketamine chain clinics as a substitute of working with their present psychotherapist).
We’re at present working in 7 states throughout the US and within the strategy of increasing throughout the nation as we construct out our medical workforce of prescribers.

What’s your online business mannequin?
We cost a membership charge of $200/month to psychotherapists, which supplies them entry to our platform, enabling them to ship KAP of their observe. Our providing consists of on-demand entry to a world-class medical workforce, in-depth KAP schooling and coaching alternatives, entry to a neighborhood of friends, and a strong library {of professional} sources. On the affected person aspect, we cost $250 for a one-time medical consumption session and $150 for follow-up periods.  We don’t make any cash from the ketamine itself, retaining prices to a minimal for the affected person.

We cost a membership charge of $200/month to psychotherapists, which supplies them entry to our platform, enabling them to ship KAP of their observe. Our providing consists of on-demand entry to a world-class medical workforce, in-depth KAP schooling and coaching alternatives, entry to a neighborhood of friends, and a strong library {of professional} sources. On the affected person aspect, we cost $250 for a one-time medical consumption session and $150 for follow-up periods.  We don’t make any cash from the ketamine itself, retaining prices to a minimal for the affected person.

How are you getting ready for a possible financial slowdown?
At Journey Medical, we offer high-quality psychological well being therapy at scale throughout a time when psychological well being challenges are extra prevalent than ever.  The necessity for efficient psychological well being care is large — the market dimension being greater than 50 million folks and rising, and the variety of folks in remedy now being ~40 million. We see an amazing want for the service we offer.
We’ve been in a position to function at a lean capability and guarantee excessive development during the last quarter within the midst of a market downturn. Our elevate permits us to have enough runway to proceed to develop the group. As founders, we perceive the significance of remaining lean as we now have been in a position to do efficiently since launching on the peak of the COVID-19 pandemic. Regardless of the market downturn, we had been in a position to elevate capital from a Tier 1 investor, giving us confidence to proceed to scale and keep bold development targets.

What was the funding course of like?
Our most up-to-date spherical was an $8.5M Sequence A. We had an amazing quantity of curiosity: we had been oversubscribed and proud to have partnered with Union Sq. Ventures because the lead.  That is actually a testomony to the standard of our mannequin and the necessity to construct efficient, scalable psychological well being options.

What are the largest challenges that you just confronted whereas elevating capital?
Each fundraise is difficult in its personal means, usually an train of dealing with rejection with grace.  As well as, we had been elevating throughout a market downtown, which was difficult in and of itself – the general temper of buyers was conservative at greatest.  Regardless of this, we ended up with an amazing quantity of curiosity: we had been oversubscribed this spherical and efficiently raised this spherical with Union Sq. Ventures because the lead.  That is actually a testomony to the standard of our mannequin and the necessity to construct efficient, scalable psychological well being options.

What elements about your online business led your buyers to write down the examine?
As Rebecca Kaden wrote in USV’s thesis about Journey Medical:

“Within the face of this, PAP (psychedelic-assisted psychotherapy) stands out as a transformational alternative. PAP facilities on therapists using psychedelics of their work with sufferers. Medical trials, which now quantity within the 1000’s, present outsized outcomes which are each efficient for sufferers with circumstances which are immune to different therapies and considerably longer lasting.

The chance round PAP and USV’s thesis round highly effective networks which are transformational to the markets they’re inbuilt led us to Journey Medical. Journey is constructing a decentralized clinic and B2B market, empowering psychotherapists to offer psychedelic therapies to their sufferers. The platform gives coaching, neighborhood, and assist for its therapist members in addition to entry to a secure and thorough prescribing community for his or her sufferers. Sufferers can in flip now entry new therapy choices by way of their present trusted suppliers in a secure and supervised means. Right now, this implies the community of Journey therapists is ready to make the most of ketamine for KAP (ketamine-assisted psychotherapy), which has been an FDA-approved drug for many years and has emerged as an vital possibility for treating despair. Because the examined and permitted therapies broaden–with MDMA and psilocybin deep in scientific trials and exhibiting very promising outcomes–Journey’s providing will, too.”

What are the milestones you propose to attain within the subsequent six months?
Within the subsequent six months, we plan to proceed a fast enhance in our platform development and utilization. We have already got sturdy shopper acquisition and retention for psychotherapists and sufferers alike, and can work to maintain and enhance our metrics whereas persevering with to construct out a compelling providing that addresses the wants of our stakeholders.  We’re additionally trying to rent for quite a few key roles, together with management roles.

Within the subsequent six months, we plan to proceed a fast enhance in our platform development and utilization. We have already got sturdy shopper acquisition and retention for psychotherapists and sufferers alike, and can work to maintain and enhance our metrics whereas persevering with to construct out a compelling providing that addresses the wants of our stakeholders.  We’re additionally trying to rent for quite a few key roles, together with management roles.

What recommendation are you able to supply corporations in New York that should not have a contemporary injection of capital within the financial institution?
The primary piece of recommendation that I’d supply is to concentrate on remaining lean and retaining burn down as we head into more and more difficult market circumstances.
The following is to take care of the resilience and relentlessness to maintain going by way of the method of talking to buyers.  Each founder goes by way of the troublesome strategy of rejection.  I’d concentrate on taking that rejection, waking up the following morning, and preserve going.  Discovering routines in your life that permit you to really feel rejection or troublesome feelings will help, and remembering that you just’re not alone–rejection is part of the method of being a founder, and you must preserve going.
Lastly, it’s actually vital to imagine in your mission, your self, and having religion in your capability to construct an incredible enterprise. Not solely will this mindset aid you, however it’s additionally one thing that actually resonates with buyers too.

The place do you see the corporate going now over the close to time period?
We’ve got established ourselves because the #1 resolution for enabling psychological well being professionals to include Psychedelic-Assisted Psychotherapy of their observe at scale.  We see ourselves cementing our place because the market chief within the area, and persevering with to develop to offer these therapies to as many eligible sufferers as potential.

What’s your favourite restaurant within the metropolis?

Shoo Shoo by my good good friend Albert Bitton.

---

You’re seconds away from signing up for the most well liked listing in Tech!

Join as we speak

---